These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 39220196)

  • 21. Encapsulation of STING Agonist cGAMP with Folic Acid-Conjugated Liposomes Significantly Enhances Antitumor Pharmacodynamic Effect.
    Lu X; Cheng H; Xu Q; Tan X
    Cancer Biother Radiopharm; 2023 Oct; 38(8):543-557. PubMed ID: 33719535
    [No Abstract]   [Full Text] [Related]  

  • 22. piSTING: A Pocket-Independent Agonist Based on Multivalency-Driven STING Oligomerization.
    Zhuo SH; Wang TY; Zhao L; Su JY; Hu JJ; Zhao YF; Li YM
    Angew Chem Int Ed Engl; 2024 Sep; 63(38):e202407037. PubMed ID: 38767062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, Synthesis and Biological Evaluation of (2',5' and 3'5'-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING).
    Xie X; Liu J; Wang X
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33198423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-delivery of doxorubicin and STING agonist cGAMP for enhanced antitumor immunity.
    Xie Y; Li K; Liang J; Wang K; Gong Z; Chen X
    Int J Pharm; 2024 Apr; 654():123955. PubMed ID: 38423155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
    Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy.
    Li Y; Yi J; Ma R; Wang Y; Lou X; Dong Y; Cao Y; Li X; Wang M; Dang X; Li R; Lei N; Song H; Qin Z; Yang W
    J Control Release; 2024 Sep; 373():447-462. PubMed ID: 39038546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity.
    Mekers VE; Kho VM; Ansems M; Adema GJ
    Radiother Oncol; 2022 Sep; 174():158-167. PubMed ID: 35870728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microparticle Delivery of a STING Agonist Enables Indirect Activation of NK Cells by Antigen-Presenting Cells.
    Watkins-Schulz R; Batty CJ; Stiepel RT; Schmidt ME; Sandor AM; Chou WC; Ainslie KM; Bachelder EM; Ting JP
    Mol Pharm; 2022 Sep; 19(9):3125-3138. PubMed ID: 35913984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATP-elicited Cation Fluxes Promote Volume-regulated Anion Channel LRRC8/VRAC Transport cGAMP for Antitumor Immunity.
    Wang L; Cao L; Li Z; Shao Z; Chen X; Huang Z; He X; Zheng J; Liu L; Jia XM; Xiao H
    J Immunol; 2024 Aug; 213(3):347-361. PubMed ID: 38847616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs.
    Li L; Yin Q; Kuss P; Maliga Z; Millán JL; Wu H; Mitchison TJ
    Nat Chem Biol; 2014 Dec; 10(12):1043-8. PubMed ID: 25344812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refractoriness of STING therapy is relieved by AKT inhibitor through effective vascular disruption in tumour.
    Jeong SH; Yang MJ; Choi S; Kim J; Koh GY
    Nat Commun; 2021 Jul; 12(1):4405. PubMed ID: 34285232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment.
    Wang Z; Miao F; Gu L; Zhang R; Ma Y; Li Y; Zheng J; Lin Z; Gao Y; Huang L; Shen Y; Wu T; Luo F; Li W
    ACS Nano; 2024 Sep; 18(35):24219-24235. PubMed ID: 39172516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization.
    Downey CM; Aghaei M; Schwendener RA; Jirik FR
    PLoS One; 2014; 9(6):e99988. PubMed ID: 24940883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells.
    Gutjahr A; Papagno L; Nicoli F; Kanuma T; Kuse N; Cabral-Piccin MP; Rochereau N; Gostick E; Lioux T; Perouzel E; Price DA; Takiguchi M; Verrier B; Yamamoto T; Paul S; Appay V
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy.
    Luo T; Nash GT; Jiang X; Feng X; Mao J; Liu J; Juloori A; Pearson AT; Lin W
    Adv Mater; 2022 Sep; 34(39):e2110588. PubMed ID: 35952624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-Dose Physically Cross-Linked Hyaluronic Acid and Lipid Hybrid Nanoparticles Containing Cyclic Guanosine Monophosphate-Adenosine Monophosphate Eliminate Established Tumors.
    Yu J; Li X; Li J; Sun N; Cheng P; Huang J; Li S; Kuai R
    ACS Nano; 2024 Oct; 18(43):29942-29955. PubMed ID: 39418110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged activation of innate immune pathways by a polyvalent STING agonist.
    Li S; Luo M; Wang Z; Feng Q; Wilhelm J; Wang X; Li W; Wang J; Cholka A; Fu YX; Sumer BD; Yu H; Gao J
    Nat Biomed Eng; 2021 May; 5(5):455-466. PubMed ID: 33558734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of MHI148 Targeted Photodynamic Therapy and STING Activation Inhibits Tumor Metastasis and Recurrence.
    Yu H; Chen Q; Zheng M; Wang R; Wang H; Cheng L; Hu Y; Dai M; Du C; Luo W; Tan M; Cao Y; Guo Y; Ran H
    ACS Appl Mater Interfaces; 2024 Jun; 16(23):29672-29685. PubMed ID: 38813586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic.
    Chin EN; Yu C; Vartabedian VF; Jia Y; Kumar M; Gamo AM; Vernier W; Ali SH; Kissai M; Lazar DC; Nguyen N; Pereira LE; Benish B; Woods AK; Joseph SB; Chu A; Johnson KA; Sander PN; Martínez-Peña F; Hampton EN; Young TS; Wolan DW; Chatterjee AK; Schultz PG; Petrassi HM; Teijaro JR; Lairson LL
    Science; 2020 Aug; 369(6506):993-999. PubMed ID: 32820126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological Activation of cGAS for Cancer Immunotherapy.
    Garland KM; Rosch JC; Carson CS; Wang-Bishop L; Hanna A; Sevimli S; Van Kaer C; Balko JM; Ascano M; Wilson JT
    Front Immunol; 2021; 12():753472. PubMed ID: 34899704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.